Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur Surg Res ; 52(1-2): 63-72, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24777108

RESUMEN

BACKGROUND: Protective loop ileostomies in colorectal surgery are constructed to reduce morbidity and reinterventions related to the primary operation. However, ileostomies are associated with stoma-related morbidity and postoperative complications following reversal surgery. Dutch national data show increased use of loop ileostomies in colorectal surgery for cancer justifying an adequate assessment of its morbidity. This study was undertaken to investigate morbidity associated with protective loop ileostomies in colorectal surgery. METHODS: Retrospectively, 118 consecutive patients undergoing left-sided colonic or rectal resection with protective loop ileostomy were included. Primary outcome was 30-day mortality. Secondary endpoints included total complication rate (including stoma-related morbidity), total reintervention risk, anastomotic leakage risk and total length of stay. RESULTS: No mortality was observed. Overall major complication, reintervention and anastomotic leakage risk for colorectal surgery were 20, 20 and 3.9%, respectively. Combined length of stay for stoma-related morbidity and reversal surgery was 12.7 days. The risk for stoma-related morbidity was 35%, and the risk for nonelective reversal was 12%. Closure rate (mean follow-up of 15 months) was 87% with a mean interval of 125 days. Reversal surgery was not correlated with mortality but with major complications (11%) and reintervention risk, anastomotic leakage risk (3.8%) and a mean length of stay of 9 days. CONCLUSION: Construction of loop ileostomies in left-sided colonic or rectal resection is associated with a low risk for anastomotic leakage at the expense of substantial stoma-related morbidity and morbidity related to reversal surgery. More accurate identification of colorectal cancer patients benefitting from protective loop ileostomy seems to be warranted.


Asunto(s)
Neoplasias del Colon/cirugía , Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Ileostomía/métodos , Neoplasias del Recto/cirugía , Anciano , Fuga Anastomótica/etiología , Fuga Anastomótica/prevención & control , Procedimientos Quirúrgicos del Sistema Digestivo/efectos adversos , Procedimientos Quirúrgicos del Sistema Digestivo/mortalidad , Femenino , Humanos , Ileostomía/efectos adversos , Ileostomía/mortalidad , Tiempo de Internación , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Reoperación/efectos adversos , Reoperación/métodos , Estudios Retrospectivos
2.
Surg Endosc ; 25(1): 1-9, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20552372

RESUMEN

BACKGROUND: Laparoscopic surgery has been incorporated into common surgical practice. The peritoneum is an organ with various biologic functions that may be affected in different ways by laparoscopic and open techniques. Clinically, these alterations may be important in issues such as peritoneal metastasis and adhesion formation. METHODS: A literature search using the Pubmed and Cochrane databases identified articles focusing on the key issues of laparoscopy, peritoneum, inflammation, morphology, immunology, and fibrinolysis. RESULTS: Laparoscopic surgery induces alterations in the peritoneal integrity and causes local acidosis, probably due to peritoneal hypoxia. The local immune system and inflammation are modulated by a pneumoperitoneum. Additionally, the peritoneal plasmin system is inhibited, leading to peritoneal hypofibrinolysis. CONCLUSION: Similar to open surgery, laparoscopic surgery affects both the integrity and biology of the peritoneum. These observations may have implications for various clinical conditions.


Asunto(s)
Laparoscopía/efectos adversos , Cavidad Peritoneal/fisiopatología , Peritoneo/fisiopatología , Neumoperitoneo Artificial/efectos adversos , Acidosis/etiología , Animales , Dióxido de Carbono/administración & dosificación , Dióxido de Carbono/efectos adversos , Moléculas de Adhesión Celular/metabolismo , Hipoxia de la Célula , Citocinas/metabolismo , Epitelio/patología , Fibrinolisina/fisiología , Fibrinólisis , Humanos , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Macrófagos Peritoneales/fisiología , Ratones , Siembra Neoplásica , Cavidad Peritoneal/cirugía , Neoplasias Peritoneales/secundario , Peritoneo/inmunología , Peritoneo/cirugía , Peritonitis/etiología , Peritonitis/fisiopatología , Adherencias Tisulares/etiología , Adherencias Tisulares/fisiopatología , Cicatrización de Heridas/fisiología
3.
Surg Endosc ; 22(5): 1232-6, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-17943363

RESUMEN

BACKGROUND: Laparoscopic surgery is evolving rapidly. It involves the creation of a pneumoperitoneum, mostly using carbon dioxide. Cooling of the peritoneum, due to insufflation, might traumatize the peritoneum and disturb peritoneal fibrinolysis, important in peritoneal healing processes. The current study was performed to elucidate the effects of the temperature of insufflation gas on the peritoneal fibrinolytic response to laparoscopic surgery. METHODS: Thirty patients scheduled for laparoscopic cholecystectomy were randomized in two groups: one group in which the pneumoperitoneum was created with carbon dioxide at room temperature, and one wherein carbon dioxide at body temperature was used. Peritoneal biopsies were taken at the start and at the end of surgery. Tissue concentrations of tPA antigen, tPA activity, uPA antigen, and PAI-1 antigen were measured using ELISA techniques. RESULTS: Peritoneal PAI-1 antigen levels were significantly higher at the end of the procedure in patients operated with carbon dioxide at room temperature (p < .05). A slight, but not significant, decrease in tPA antigen and activity was observed in both groups during the procedure. Peritoneal concentrations of uPa antigen did not change during the procedure. CONCLUSIONS: The temperature of carbon dioxide used for insufflation of the abdominal cavity affects peritoneal biology. Cooling of the peritoneum by unheated carbon dioxide causes increased peritoneal PAI-1 levels, important in peritoneal healing processes.


Asunto(s)
Dióxido de Carbono/administración & dosificación , Colecistectomía Laparoscópica/métodos , Calor/uso terapéutico , Insuflación/métodos , Peritoneo/efectos de los fármacos , Adulto , Anciano , Femenino , Fibrinólisis , Humanos , Masculino , Persona de Mediana Edad , Peritoneo/metabolismo , Peritoneo/patología , Inhibidor 1 de Activador Plasminogénico/metabolismo , Antígeno Polipéptido de Tejido/efectos de los fármacos , Antígeno Polipéptido de Tejido/metabolismo , Resultado del Tratamiento , Activador de Plasminógeno de Tipo Uroquinasa/efectos de los fármacos , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
4.
Eur J Surg Oncol ; 27(4): 409-13, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11417989

RESUMEN

BACKGROUND: This study was designed to evaluate the development of malignancies after renal transplantation in a single centre. The outcome was studied in patients developing a malignant neoplasm after renal transplantation. METHODS: Malignancies are registered in a database containing relevant data about the patients with a renal transplant. This database and the files of the patients developing a malignant neoplasm, have been studied as to stage at presentation, therapy and outcome. RESULTS: In 1546 patients with 2075 renal transplantations, 240 malignancies developed in 231 recipients. Skin cancers often present with more than one lesion of the same histological type. After the first skin tumour, about half of the patients developed more lesions, of the same or a different histological type. The prognosis of skin tumours is relatively good, but most malignancies in all other categories have a poor prognosis. CONCLUSIONS: Cutaneous neoplasms tend to be multiple, but can be controlled by regular examination of the skin. Most malignant lymphomas do develop outside the lymphoproliferative system and have a poor prognosis. Patients with a solid tumour of the other tracts often present in an advanced stage of disease, which makes the outcome of treatment, if possible at all, disappointing.


Asunto(s)
Inmunosupresores/efectos adversos , Trasplante de Riñón , Neoplasias/epidemiología , Adulto , Anciano , Femenino , Neoplasias Gastrointestinales/epidemiología , Neoplasias de Cabeza y Cuello/epidemiología , Humanos , Incidencia , Trastornos Linfoproliferativos/epidemiología , Masculino , Persona de Mediana Edad , Neoplasias/inmunología , Países Bajos/epidemiología , Pronóstico , Neoplasias del Sistema Respiratorio/epidemiología , Estudios Retrospectivos , Neoplasias Cutáneas/epidemiología , Neoplasias de los Tejidos Blandos/epidemiología , Factores de Tiempo , Trasplante Homólogo , Neoplasias Urogenitales/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA